Versant Venture Management, LLC
8 holdingsFiling period: 2026-03-31Current AUM: $138.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics, Inc. | 3.18M | $52.3M | $52.5M | 37.97% | -1,201,907 | 2026-03-31 |
| 2 | IPSC | Century Therapeutics, Inc. | 12.17M | $27.5M | $24.6M | 17.76% | -- | 2026-03-31 |
| 3 | LENZ | Lenz Therapeutics, Inc. | 2.66M | $24.3M | $14.1M | 10.17% | -- | 2026-03-31 |
| 4 | JBIO | Jade Biosciences, Inc. | 1.53M | $21.4M | $30.1M | 21.77% | -- | 2026-03-31 |
| 5 | CTNM | Contineum Therapeutics, Inc. | 542.6K | $7.1M | $8.4M | 6.07% | -- | 2026-03-31 |
| 6 | — | CRISPR Therapeutics AG | 148.8K | $7.1M | $7.1M | 5.11% | -- | 2026-03-31 |
| 7 | SKYE | Skye Bioscience, Inc. | 2.01M | $1.2M | $1.1M | 0.82% | -- | 2026-03-31 |
| 8 | OVAS | Tempest Therapeutics, Inc. | 269.8K | $442K | $442K | 0.32% | -- | 2026-03-31 |
← Scroll →